Midwives’ experience of telehealth and remote care: a systematic mixed methods review.

Publication date: Mar 29, 2024

Increasing the midwifery workforce has been identified as an evidence-based approach to decrease maternal mortality and reproductive health disparities worldwide. Concurrently, the profession of midwifery, as with all healthcare professions, has undergone a significant shift in practice with acceleration of telehealth use to expand access. We conducted a systematic literature review to identify and synthesize the existing evidence regarding how midwives experience, perceive and accept providing sexual and reproductive healthcare services at a distance with telehealth. Five databases were searched, PubMed, CINHAL, PsychInfo, Embase and the Web of Science, using search terms related to ‘midwives’, ‘telehealth’ and ‘experience’. Peer-reviewed studies with quantitative, qualitative or mixed methods designs published in English were retrieved and screened. Studies meeting the inclusion criteria were subjected to full-text data extraction and appraisal of quality. Using a convergent approach, the findings were synthesized into major themes and subthemes. After applying the inclusion/exclusion criteria, 10 articles on midwives’ experience of telehealth were reviewed. The major themes that emerged were summarized as integrating telehealth into clinical practice; balancing increased connectivity; challenges with building relationships via telehealth; centring some patients while distancing others; and experiences of telehealth by age and professional experience. Most current studies suggest that midwives’ experience of telehealth is deeply intertwined with midwives’ experience of the response to COVID-19 pandemic in general. More research is needed to understand how sustained use of telehealth or newer hybrid models of telehealth and in-person care are perceived by midwives.

Open Access PDF

Concepts Keywords
Databases Health Equity
English Health Services
Healthcare Maternal medicine
Midwives Reproductive medicine
Pandemic Telemedicine


Type Source Name
disease IDO quality
disease MESH COVID-19 pandemic
disease VO USA
disease VO population
disease VO organization
disease MESH preterm births
disease IDO intervention
drug DRUGBANK Methionine
drug DRUGBANK Coenzyme M
disease IDO country
disease VO device
disease VO protocol
drug DRUGBANK Trestolone
disease MESH infection
drug DRUGBANK Isoxaflutole
disease MESH loneliness
disease MESH violence
disease VO frequency
disease VO volume
disease VO age
disease VO Equity
drug DRUGBANK Etoperidone
disease MESH domestic violence
disease IDO blood
disease VO report
disease VO Gap
drug DRUGBANK Pentaerythritol tetranitrate
disease IDO process
disease MESH emergency
pathway REACTOME Translation
disease VO pregnant women

Original Article

(Visited 1 times, 1 visits today)